Short QT Syndrome and Early Repolarization Syndrome

SQTS is caused by mutations that accelerate repolarization. Two classes of mutations achieve this:

Gain-of-function potassium channel mutations increase outward repolarizing current. More potassium leaves the cell during repolarization, so the action potential terminates sooner. SQT1 involves KCNH2 (encoding the I_Kr channel), SQT2 involves KCNQ1 (I_Ks), and SQT3 involves KCNJ2 (I_K1).

Loss-of-function calcium channel mutations reduce inward depolarizing current during the plateau. With less calcium current holding the membrane positive, repolarization accelerates. SQT4 involves CACNA1C and SQT5 involves CACNB2 (the same genes implicated in Brugada syndrome, reflecting mechanistic overlap).

Both classes produce the same end result: the action potential duration shortens, the effective refractory period abbreviates, and the tissue becomes excitable again too soon after each beat.

Reentry requires a circuit length that exceeds the wavelength of the electrical impulse. Wavelength equals conduction velocity multiplied by the refractory period. If conduction velocity stays constant but the refractory period drops from 250 ms to 180 ms, the wavelength shrinks proportionally.

A shorter wavelength means the impulse can complete a smaller circuit and still find recovered tissue ahead of it. The excitable gap (the portion of the circuit that has already recovered and is ready to be re-excited) becomes disproportionately large relative to the circuit. This makes it easy for wavefronts to fragment and sustain multiple small reentrant circuits simultaneously. That is fibrillation.

In SQTS, ventricular ERPs measured in the EP lab are often below 200 ms (normal is 230-280 ms). VF is easily induced with programmed stimulation, sometimes with a single extrastimulus.

The defining feature is a corrected QT interval below 340 ms (some criteria use < 360 ms in patients with symptoms or family history). The absolute QT interval may be strikingly short, often below 300 ms even at normal heart rates.

T waves are tall, peaked, and narrow-based. Rapid repolarization produces a steep voltage change over a brief time, generating a sharp, pointed T wave. This is the visual signature of accelerated Phase 3.

The ST segment is very short or absent. The T wave begins almost immediately after the QRS complex because there is minimal plateau phase before repolarization begins its descent.

A distinctive feature of SQTS is that the QT interval fails to shorten appropriately with increasing heart rate. In normal physiology, the QT adapts significantly to rate changes. In SQTS, the QT is already near its minimum and has little room to shorten further. This produces a "flat" QT-rate relationship.

SQTS is extremely rare. Fewer than 200 cases have been reported worldwide. The rarity makes population-level risk stratification difficult.

Clinical triggers for suspicion include a family history of sudden cardiac death at a young age, unexplained cardiac arrest, or atrial fibrillation presenting unusually early (the short atrial refractory periods predispose to AF as well). In many cases, VF is the first clinical presentation, often in adolescents or young adults.

In the EP lab, ventricular effective refractory periods are characteristically short (often < 200 ms at multiple RV sites). VF is easily inducible, sometimes with a single premature extrastimulus at long coupling intervals. This ease of induction correlates with clinical risk.

The early repolarization pattern is defined as J-point elevation of at least 1 mm (0.1 mV) in two or more contiguous inferior or lateral leads, with notching or slurring of the terminal QRS. This pattern is common: it appears in 5-10% of the general population, with higher prevalence in young men and athletes.

For decades, early repolarization was considered universally benign. Studies in 2008 challenged this assumption by demonstrating a statistical association between the inferior ER pattern and idiopathic VF. The association is real but the absolute risk is vanishingly small for any individual.

Early Repolarization Syndrome (ERS) is the rare malignant form. It is diagnosed only retrospectively, in patients who have the ER pattern AND have survived idiopathic VF or unexplained cardiac arrest. The pattern alone, without an arrhythmic event, remains a benign finding in the overwhelming majority of individuals who carry it.

The mechanism parallels Brugada syndrome. In certain individuals, a prominent transient outward potassium current (I_to) causes regional epicardial shortening of Phase 2 (the plateau). The epicardial action potential loses its dome while the endocardium retains it.

This creates transmural voltage dispersion. The epicardial surface repolarizes early while the endocardium remains depolarized. The voltage gradient between these layers manifests as J-point elevation on the surface ECG.

When the dispersion is severe enough, current flows from the still-depolarized endocardium back to the already-repolarized (and thus re-excitable) epicardium. This can trigger a local re-excitation called Phase 2 reentry, which produces a closely-coupled premature beat that may initiate VF.

The distinction between Brugada syndrome and ERS may be primarily anatomical rather than mechanistic. In Brugada, the affected epicardium is concentrated in the right ventricular outflow tract. In ERS, it is distributed across the inferolateral wall. The underlying ionic mechanism (prominent I_to creating Phase 2 dispersion) appears to be the same.

Short QT Syndrome: The ICD is the primary therapy for patients who have survived cardiac arrest or who have a strong family history of SCD with documented short QT intervals. Quinidine serves as adjunctive pharmacotherapy. It blocks both I_Kr and I_to, prolonging repolarization and increasing the refractory period. In patients where ICD implantation is not feasible (young children, patient refusal), quinidine may be used as primary prophylaxis.

A practical challenge with ICDs in SQTS: the tall, peaked T waves can cause T-wave oversensing, leading to inappropriate shocks. Programming adjustments (higher detection thresholds, longer detection windows) are often necessary.

Early Repolarization Syndrome: An ICD is indicated for survivors of cardiac arrest. For patients with recurrent VF storms, isoproterenol acutely (to augment the calcium current and restore the epicardial dome) followed by quinidine chronically may suppress the arrhythmia substrate.

The benign ER pattern: No intervention. No restriction. No monitoring beyond standard care. The challenge, and the reason this topic generates clinical anxiety, is distinguishing the benign majority from the rare malignant minority in the absence of a prior event. Currently, there is no reliable way to make this distinction prospectively.